Potential neuroleptic agents. 2. Synthesis and dopamine blocking activity of some new 2,6-dimethoxybenzamide derivatives.

No abstract is available for this paper.

• Publication year

  1983

• Venue

  Acta pharmaceutica Suecica

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 6141698
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Potential neuroleptic agents. 2,6-Dialkoxybenzamide derivatives with potent dopamine receptor blocking activities.

  1982cited by this paper

• The role of dopaminergic transmission through D1-like and D2-like receptors in amphetamine-induced rat ultrasonic vocalizations

  2012cites this paper
• Quantum Biochemistry Description of the Human Dopamine D3 Receptor in Complex with the Selective Antagonist Eticlopride

  2012cites this paper
• Effect of lipophilicity of substituted benzamides on the dopaminergic effects in vivo and in vitro.

  2009cites this paper
• Role of dopamine and glutamate receptors in cocaine-induced social effects in isolated and grouped male OF1 mice.

  2005cites this paper
• Remoxipride, a selective dopamine D2 receptor antagonist, in tardive dyskinesia

  2004cites this paper
• Biotransformation of Post-Clozapine Antipsychotics

  2000cites this paper
• A simple method of preparation for [123I]-(S)-(-)-IBZM.

  1998cites this paper
• Multiway calibration in 3D QSAR

  1997cites this paper
• In vivo effects of remoxipride and aromatic ring metabolites in the rat.

  1997cites this paper
• DEVELOPMENT OF FLUORINE-18 RADIOPHARMACEUTICALS FOR DOPAMINE NEURORECEPTORS

  1995cites this paper
• Dopamine D2 Receptor Blockade and Antimigraine Action of Flunarizine

  1994cites this paper
• Quality Assurance and Quality Control of Short-Lived Radiopharmaceuticals for PET

  1993cites this paper
• Iodinated Dopamine D1 and D2 Receptor Imaging Agents for SPECT

  1993cites this paper
• Determination of remoxipride in human plasma and urine by reversed-phase ion-pair high-performance liquid chromatography.

  1992cites this paper
• Optimization of a peak compression system for a remoxipride metabolite (FLA797) and its application to bioanalysis.

  1992cites this paper
• Design and Radiofluorination of Benzamide Dopamine D2 Receptor Ligands

  1991cites this paper
• Radioligands for Dopamine Receptor PET Studies: Benzamides and Ligands for Dopamine D-1 Receptors

  1991cites this paper
• High affinity dopamine D2 receptor radioligands. 1. Regional rat brain distribution of iodinated benzamides.

  1991cites this paper
• Determination of remoxipride in plasma and urine by reversed-phase column liquid chromatography.

  1990cites this paper
• Radiopharmaceuticals for CNS receptor imaging with SPECT.

  1990cites this paper
• Remoxipride — a new potential antipsychotic compound

  1989cites this paper
• Animal pharmacology of raclopride, a selective dopamine D2 antagonist.

  1989cites this paper
• Remoxipride — a new potential antipsychotic drug

  1988cites this paper
• New selective dopamine D-2 antagonists as antipsychotic agents. Pharmacological, chemical, structural and theoretical considerations.

  1987cites this paper
• Recent news in the chemistry and pharmacology of neuroleptics with special regard to the work carried out in Czechoslovakia.

  1986cites this paper
• Autoradiographic visualization of dopamine D-2 receptors in the monkey brain using the selective benzamide drug [3H]raclopride.

  1986cites this paper
• Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain.

  1985cites this paper
• Potential neuroleptic agents. 3. Chemistry and antidopaminergic properties of substituted 6-methoxysalicylamides.

  1985cites this paper
• Remoxipride, a new potential antipsychotic compound with selective antidopaminergic actions in the rat brain.

  1984cites this paper